| COVID-19 |
1 |
1 |
| Child |
0 |
0.99 |
| COVID-19 Vaccine |
0 |
0.49 |
| Obesity |
0 |
0.48 |
| Arrhythmia |
0 |
0.98 |
| Cardiomyopathy |
0 |
0.31 |
| Young Adult |
0 |
0.31 |
| Severe Acute Respiratory Syndrome |
0 |
0.23 |
| Acute Respiratory Distress Syndrome |
0 |
0.21 |
| Myocarditis |
0 |
0.97 |
| Vaccines |
0 |
0.19 |
| Heart |
0 |
0.17 |
| Cardiac MRI |
0 |
0.16 |
| Cardiovascular Imaging |
0 |
0.16 |
| Atrioventricular Block |
0 |
0.15 |
| Heart Failure (HF) |
0 |
0.14 |
| Congenital Heart Disease |
0 |
0.13 |
| Artery |
0 |
0.11 |
| Pandemic |
0 |
0.11 |
| Ventricular Tachycardia |
0 |
0.1 |
| Tachycardia |
0 |
0.09 |
| Atrial Tachycardia |
0 |
0.08 |
| Clinical Research |
0 |
0.06 |
| Exercise |
0 |
0.06 |
| Immunization |
0 |
0.06 |
| Intravenous Immunoglobulin (IVIG) |
0 |
0.06 |
| Troponin |
0 |
0.06 |
| Aneurysm |
0 |
0.05 |
| Deep Venous Thrombosis |
0 |
0.05 |
| Platelet Count |
0 |
0.05 |
| Pulmonary Embolism |
0 |
0.05 |
| Adolescent Medicine |
0 |
0.03 |
| Anticoagulation Therapy |
0 |
0.03 |
| Antiviral Agents |
0 |
0.03 |
| Aspirin |
0 |
0.03 |
| B-Type Natriuretic Peptide |
0 |
0.03 |
| C-Reactive Protein (CRP) |
0 |
0.03 |
| Colorado |
0 |
0.03 |
| Echocardiography |
0 |
0.03 |
| Electrocardiogram (ECG) |
0 |
0.03 |
| Health Care Inequities |
0 |
0.03 |
| Hospital |
0 |
0.03 |
| Hypertrophic Cardiomyopathy |
0 |
0.03 |
| Immunocompromise |
0 |
0.03 |
| Intensive Care Unit |
0 |
0.03 |
| Intravenous |
0 |
0.03 |
| Lung |
0 |
0.03 |
| Magnetic Resonance Imaging |
0 |
0.03 |
| Pericardial Effusion |
0 |
0.03 |
| Pericarditis |
0 |
0.03 |
| Prognosis |
0 |
0.03 |
| Shock |
0 |
0.03 |
| Sudden Cardiac Death |
0 |
0.03 |
| Asthma |
0 |
0.02 |
| Electrophysiology |
0 |
0.02 |
| Myocardial Infarction (MI) |
0 |
0.02 |
| Social Determinants of Health |
0 |
0.02 |